NCT01616342

Brief Summary

The purpose of this study is to determine the degree to which spinal cord stimulation added to comprehensive medical management can provide increased relief of chronic pain in patients with injuries sustained while on active military duty, measured by patient assessments of pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Dec 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2011

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2011

Completed
6 months until next milestone

First Posted

Study publicly available on registry

June 11, 2012

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

June 11, 2012

Status Verified

June 1, 2012

Enrollment Period

2 years

First QC Date

October 26, 2011

Last Update Submit

June 7, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in pain score

    Change from Baseline to Week 24 in weekly mean of average daily pain scores at the target site of pain (target pain, TP), based on an 11-point Numerical Pain Rating Scale (NPRS), by treatment group.

    144 weeks

Secondary Outcomes (22)

  • change in related pain

    144 weeks

  • change in mean daily pain score

    144 weeks

  • change in mean pain per treatment group

    144 weeks

  • change in MPQ per treatment group

    144 weeks

  • change in spine related pain

    144 weeks

  • +17 more secondary outcomes

Study Arms (2)

Comprehensive Medical Management

ACTIVE COMPARATOR

Comprehensive Medical Management will include analgesic management in accordance with guidelines and practices at the site.

Device: Spinal cord stimulator

Spinal Cord Stimulation (SCS)

ACTIVE COMPARATOR

Subjects assigned to Arm A, CMM + SCS, will be treated with electrical pulses from a surgically implanted Precision Plus® SCS System (Boston Scientific Corporation).

Device: Spinal cord stimulator

Interventions

Precise (TM) spinal cord stimulator from boston scientific, and comprehensive mdedical management.

Comprehensive Medical ManagementSpinal Cord Stimulation (SCS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is a veteran or active duty service member injured while on active military duty receiving care for pain related to the injury(ies) in the Department of Defense health care system or through the Department of Veteran's Affairs.
  • Subject is 18 years of age or older.
  • The elapsed time since the active-duty injury leading to chronic pain is not less than 3 months.
  • Subject reports constant or daily episodes of injury-related pain of at least moderate severity, graded 4 or higher on an 11-point NPRS (point estimate by subject and Investigator at time of enrolment based on overall pain or pain at a specific site). Pain may be nociceptive, neuropathic, or mixed. Phantom pain associated with amputation of an extremity or extremities is allowed.
  • Attempts to control pain with commercially available systemic analgesics have not provided adequate relief, in the judgment of the managing physician and subject.
  • Subject is an acceptable candidate for surgical placement of an indwelling spinal cord stimulation device.
  • Subject is judged an appropriate candidate for treatment using the available techniques and interventions encompassed within the protocol's definition of comprehensive medical management.
  • For the duration of the trial, subject is willing to limit interventions for control of chronic pain to those approved by the Investigator.
  • The subject is judged psychologically appropriate for either treatment intervention, based on the impression of an interviewing psychologist or psychiatrist.
  • Subject provides informed consent.

You may not qualify if:

  • Subject experiences phantom pain associated with amputation of both an upper and lower extremity.
  • Subject has headache or visceral truncal pain or other non-musculoskeletal pain as the only pain that results in constant or daily scores of ≥4 on the 11-point NPRS.
  • Subject has spinal disease that would, in the judgment of the investigator, - Subject has ongoing chronic infection or a medical condition associated with an unacceptably increased risk of infection related to device implantation.
  • Subject has a current diagnosis or history of psychosis, cognitive impairment, hallucinations, or unexplained loss of consciousness, whether or not related to a combat injury that, in the opinion of the investigator, would exclude the patient from participating in the trial.
  • Subject has a cardiac pacemaker.
  • Subject has any significant medical or psychiatric condition that would interfere with the conduct of the study or with the outcome measures.
  • Subject is pregnant or is breast feeding.
  • Subject has participated in any drug or device trial in the past 30 days.
  • Subject has any planned elective or semi-elective surgery during the 6 months of the Primary Treatment Phase, including stump revisions or grafting.
  • Subject has a psychological condition of great enough severity that it would unacceptably increase the medical risks associated with implantation and care of the devices required for the treatment on the CMM + SCS arm, or would likely interfere with the subject's ability to sustain participation in a research study of long duration. Investigators are encouraged to include the medical monitor and the coordinating investigator in discussions about individual candidate subjects who have psychological diagnoses as part of the polytrauma syndrome before enrollment or treatment on this protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Clinical Research

Winston-Salem, North Carolina, 27103, United States

RECRUITING

Related Links

Study Officials

  • Richard Rauck, MD

    The Center for Clinical Research

    PRINCIPAL INVESTIGATOR
  • Derry Ridgeway, MD

    SRA International

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2011

First Posted

June 11, 2012

Study Start

December 1, 2011

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

June 11, 2012

Record last verified: 2012-06

Locations